Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424).

Brown, Gary C; Brown, Melissa M

Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424).

Brown, Gary C; Brown, Melissa M.

Affiliation

Brown GC; Center for Value-Based Medicine, Hilton Head, South Carolina; Wills Eye Hospital, Philadelphia, Pennsylvania; The Eye Research Institute, Philadelphia, Pennsylvania; Thomas Jefferson Medical University, Philadelphia, Pennsylvania; Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia. Electronic address: gary0514@gmail.com.
Brown MM; Center for Value-Based Medicine, Hilton Head, South Carolina; Wills Eye Hospital, Philadelphia, Pennsylvania; The Eye Research Institute, Philadelphia, Pennsylvania; Thomas Jefferson Medical University, Philadelphia, Pennsylvania; Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.

Ophthalmology ; 126(10): e76, 2019 10.

Article in En | MEDLINE | ID: mdl-31543114

Subject(s)

Antirheumatic Agents; Arthritis, Juvenile; Uveitis; Adalimumab; Cost-Benefit Analysis; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Juvenile / Uveitis / Antirheumatic Agents Type of study: Health_economic_evaluation / Risk_factors_studies Limits: Humans Language: En Journal: Ophthalmology Year: 2019 Type: Article

Fulltext

XML

PubMed Links

Search on Google